LLY

1,052.4

+0.79%↑

JNJ

210.33

+0.24%↑

ABBV

224.81

+0.86%↑

UNH

333.1

-0.29%↓

AZN

90.85

+0.28%↑

LLY

1,052.4

+0.79%↑

JNJ

210.33

+0.24%↑

ABBV

224.81

+0.86%↑

UNH

333.1

-0.29%↓

AZN

90.85

+0.28%↑

LLY

1,052.4

+0.79%↑

JNJ

210.33

+0.24%↑

ABBV

224.81

+0.86%↑

UNH

333.1

-0.29%↓

AZN

90.85

+0.28%↑

LLY

1,052.4

+0.79%↑

JNJ

210.33

+0.24%↑

ABBV

224.81

+0.86%↑

UNH

333.1

-0.29%↓

AZN

90.85

+0.28%↑

LLY

1,052.4

+0.79%↑

JNJ

210.33

+0.24%↑

ABBV

224.81

+0.86%↑

UNH

333.1

-0.29%↓

AZN

90.85

+0.28%↑

McKesson Corp

Отворен

СекторЗдравеопазване

800.24 -0.95

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

799.33

Максимум

812

Ключови измерители

By Trading Economics

Приходи

426M

1.2B

Продажби

5.3B

103B

P/E

Средно за сектора

25.703

77.671

EPS

9.86

Дивидентна доходност

0.36

Марж на печалбата

1.173

Служители

43,000

EBITDA

212M

1.5B

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+13.65% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.36%

2.35%

Следваща дата на дивидент

2.01.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

338M

102B

Предишно отваряне

801.19

Предишно затваряне

800.24

Настроения в новините

By Acuity

28%

72%

68 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

McKesson Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

16.12.2025 г., 23:46 ч. UTC

Пазарно говорене

Gold Edges Higher, Aided by Fed Rate-Cut Prospects -- Market Talk

16.12.2025 г., 23:38 ч. UTC

Пазарно говорене

Nikkei May Rise on Possible Bargain-Hunting Interest -- Market Talk

16.12.2025 г., 22:35 ч. UTC

Придобивния, сливания и поглъщания

Santos: Sale Delivered Cash, Reduced Future Decommissioning Exposure

16.12.2025 г., 22:35 ч. UTC

Придобивния, сливания и поглъщания

Santos Sold 43% Stake in Petrel Fields, 100% of Tern Fields to Eni Australia

16.12.2025 г., 22:33 ч. UTC

Придобивния, сливания и поглъщания

Santos: A$40M Upfront Consideration, Up to A$20M in Contingent Payments

16.12.2025 г., 22:33 ч. UTC

Придобивния, сливания и поглъщания

Santos Sold 43% Operated Interest in Mahalo JV to Comet Ridge

16.12.2025 г., 22:32 ч. UTC

Придобивния, сливания и поглъщания

Santos Divests Two Noncore Assets as Part of Portfolio Optimization

16.12.2025 г., 22:25 ч. UTC

Придобивния, сливания и поглъщания

Westgold's Indicative Timetable Points to Early February Completion

16.12.2025 г., 22:24 ч. UTC

Придобивния, сливания и поглъщания

Westgold: Divestment Aligns With Broader Corporate Strategy

16.12.2025 г., 22:23 ч. UTC

Придобивния, сливания и поглъщания

Westgold: Deferred Payment Based on Performance Hurdles

16.12.2025 г., 22:23 ч. UTC

Придобивния, сливания и поглъщания

Westgold Will Receive A$15M Cash, A$19.6M in Alicanto Shares

16.12.2025 г., 22:23 ч. UTC

Придобивния, сливания и поглъщания

Westgold to Receive A$30M Deferred Payment in Cash or Shares

16.12.2025 г., 22:22 ч. UTC

Придобивния, сливания и поглъщания

Westgold Divesting Noncore Operating Asset for A$64.6M

16.12.2025 г., 22:22 ч. UTC

Придобивния, сливания и поглъщания

Westgold Agrees to Sell Mt Henry-Selene Project to Alicanto Minerals

16.12.2025 г., 21:53 ч. UTC

Печалби

Lennar Misses Earnings Estimates. The Stock Is Dropping. -- Barrons.com

16.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

16.12.2025 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- 2nd Update

16.12.2025 г., 21:18 ч. UTC

Придобивния, сливания и поглъщания

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- Update

16.12.2025 г., 21:17 ч. UTC

Придобивния, сливания и поглъщания

Worthington Enterprises to Buy LSI Group for About $205M >WOR

16.12.2025 г., 21:16 ч. UTC

Печалби

Worthington Enterprises 2Q Sales $327.5M >WOR

16.12.2025 г., 21:16 ч. UTC

Печалби

Worthington Enterprises 2Q Adj EPS 65c >WOR

16.12.2025 г., 21:16 ч. UTC

Печалби

Worthington Enterprises 2Q EPS 55c >WOR

16.12.2025 г., 21:15 ч. UTC

Придобивния, сливания и поглъщания

Worthington Enterprises Agrees To Acquire Leading Metal Roof Components Manufacturer LSI Group >WOR

16.12.2025 г., 21:05 ч. UTC

Придобивния, сливания и поглъщания

Ecolab Closes Acquisition Of Ovivo's Electronics Ultrapure Water Business >ECL

16.12.2025 г., 20:54 ч. UTC

Придобивния, сливания и поглъщания

Warner to Reject Paramount Offer As Soon As Wednesday, Sources Say -- WSJ

16.12.2025 г., 20:54 ч. UTC

Придобивния, сливания и поглъщания

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- WSJ

16.12.2025 г., 20:54 ч. UTC

Придобивния, сливания и поглъщания

Warner to Recommend Existing Netflix Deal, Sources Say -- WSJ

16.12.2025 г., 20:44 ч. UTC

Пазарно говорене

Russia-Ukraine Peace Efforts Send Crude to Near 5-Year Low -- Market Talk

16.12.2025 г., 20:04 ч. UTC

Пазарно говорене

U.S. Natural Gas Extends Weather-Driven Losing Streak -- Market Talk

16.12.2025 г., 20:01 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

McKesson Corp Прогноза

Ценова цел

By TipRanks

13.65% нагоре

12-месечна прогноза

Среден 935.33 USD  13.65%

Висок 1,000 USD

Нисък 860 USD

Според 15 анализатори от Wall Street, предложили 12-месечна ценова цел за McKesson Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

15 ratings

13

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

681.92 / 707.28Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

No Evidence

Дългосрочен план

No Evidence

Настроение

By Acuity

68 / 374 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat